BRITTANY NEWELL: Open Payments
NPI 1083230197 · LOUISBURG, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 59 payments from 14 companies in 2025. Trend: 2023 $1,050 · 2024 $1,157 · 2025 $1,178
Food & beverage: $1,178
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $213 |
| AstraZeneca Pharmaceuticals LP | 6 | $193 |
| ABBVIE INC. | 9 | $165 |
| GlaxoSmithKline, LLC. | 7 | $144 |
| Exact Sciences Corporation | 3 | $56 |
| PFIZER INC. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Abbott Laboratories | 1 | $26 |
| Viatris Specialty LLC | 1 | $16 |
Products named: CAPLYTA, BREZTRI, TRELEGY ELLIPTA, Wegovy, Ozempic, VRAYLAR, Rybelsus, QULIPTA.
Industry payments across NC — which companies pay providers there.
